• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 POWERPICC SOLO CATHETER WITH SHERLOCK 3CG TIP POSITIONING SYSTEM; CATHETER,INTRAVASCULAR,THERAPEUTIC,LONG-TERM GREATER THAN 30 DAYS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 POWERPICC SOLO CATHETER WITH SHERLOCK 3CG TIP POSITIONING SYSTEM; CATHETER,INTRAVASCULAR,THERAPEUTIC,LONG-TERM GREATER THAN 30 DAYS Back to Search Results
Model Number N/A
Device Problem Fluid/Blood Leak (1250)
Patient Problem Extravasation (1842)
Event Date 07/07/2022
Event Type  Injury  
Event Description
It was reported patient receiving chemotherapy via picc line.Contacted nursing staff to alert that area around the insertion site was wet.Chemotherapy stopped.Line flushed.Nic informed.Discussed with and assessed by medical team.Linogram arranged and attended for same area treated as per local extravasation policy.Picc line removed.Arranged for reinsertion with infusional services following day.
 
Manufacturer Narrative
The device has not been returned to the manufacturer for evaluation.A lot history review (lhr) of refy1412 showed one other similar product complaint(s) from this lot number.
 
Manufacturer Narrative
The information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.The following were reviewed as part of this investigation: patient severity, complaint and lot history review, applicable previous investigation(s), sample (if available), applicable manufacture records, and applicable fmea documents.Based on a review of this information, the following was concluded: the complaint of a leak was confirmed.The product returned for evaluation was one 4 fr single lumen powerpicc solo catheter.The investigation findings are consistent with damage accumulated through flexural fatigue.Flexural fatigue occurs due to cyclic kinking of the catheter tube in which physiological, placement, usage, and mechanical factors may gradually form a crack(s) in the catheter.The returned product sample was evaluated, and a split was observed approximately 6.5 cm dist.To molded joint.The catheter split contained physical features associated with material fatigue, and the characteristics observed which supported this type of failure included: ¿ damage which was circumferentially aligned ¿ fracture edges which were rounded and polished due to repeated material wear ¿ 'c' shaped impressions leading into the fracture site which are consistent with material buckling due to movement which caused the fracture edges to be pressed together ¿ overall elliptical shape to the fracture cross-section (a result of repeated kinking of the tubing) an examination of the catheter structure revealed no potential damage/defect related to manufacture of the product.
 
Event Description
It was reported patient receiving chemotherapy via picc line.Contacted nursing staff to alert that area around the insertion site was wet.Chemotherapy stopped.Line flushed.Nic informed.Discussed with and assessed by medical team.Linogram arranged and attended for same area treated as per local extravasation policy.Picc line removed.Arranged for reinsertion with infusional services following day.Additional information received: "there is no evidence of tissue damage.Treatment was an irritant.The immediate treatment patient received was infusion stopped, iv device aspirated, medical team contacted/pharmacy contacted, cold pack for 20 minutes every 4 hours for 24 hours, arm elevated, topical hydrocortisone 1% cream every 6 hours for up to 7 days.Follow up the following day.".
 
Manufacturer Narrative
H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event Description
It was reported patient receiving chemotherapy via picc line.Contacted nursing staff to alert that area around the insertion site was wet.Chemotherapy stopped.Line flushed.Nic informed.Discussed with and assessed by medical team.Linogram arranged and attended for same area treated as per local extravasation policy.Picc line removed.Arranged for reinsertion with infusional services following day.Additional information received: treatment was an irritant.The immediate treatment she received was infusion stopped, iv device aspirated, medical team contacted/pharmacy contacted, cold pack for 20 minutes every 4 hours for 24 hours, arm elevated, topical hydrocortisone 1% cream every 6 hours for up to 7 days".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
POWERPICC SOLO CATHETER WITH SHERLOCK 3CG TIP POSITIONING SYSTEM
Type of Device
CATHETER,INTRAVASCULAR,THERAPEUTIC,LONG-TERM GREATER THAN 30 DAYS
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer (Section G)
BARD REYNOSA S.A. DE C.V. -9617592
blvd. montebello #1
parque industrial colonial
reynosa, tamaulipas 88780
MX   88780
Manufacturer Contact
becky garcia
605 north 5600 west
salt lake city 84116
8015950700
MDR Report Key15164408
MDR Text Key297240040
Report Number3006260740-2022-03040
Device Sequence Number1
Product Code LJS
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
K091324
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 09/20/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/04/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/30/2023
Device Model NumberN/A
Device Catalogue Number2194108
Device Lot NumberREFY1412
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/20/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/01/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-